Premium
Salvage Therapy after Two or More Prior Helicobacter pylori Treatment Failures: the Super Salvage Regimen
Author(s) -
Dore Maria Pina,
Marras Lea,
Maragkoudakis Emmanouil,
Nieddu Salvatore,
Manca Alessandra,
Graham David Y.,
Realdi Giuseppe
Publication year - 2003
Publication title -
helicobacter
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 79
eISSN - 1523-5378
pISSN - 1083-4389
DOI - 10.1046/j.1523-5378.2003.00150.x
Subject(s) - medicine , helicobacter pylori , regimen , salvage therapy , surgery , gastroenterology , breath test , evening , chemotherapy , physics , astronomy
Background. Although effective therapies are available for curing Helicobacter pylori infection, the problem persists about what to do for patients who fail two or more treatment courses despite a good compliance. Aim. To test a twice a day midday quadruple therapy as salvage therapy. Methods. Dyspeptic H. pylori‐ infected patients who failed two or more courses of anti‐ H. pylori therapy received omeprazole 20 mg, tetracycline 500 mg, metronidazole 500 mg, and bismuth subcitrate caplets 240 mg twice a day (with the midday and evening meals) for 14 days. H. pylori status was evaluated by 13 C‐urea breath test and histology 4–6 weeks after therapy. Eradication was defined as no positive test. Results. Seventy‐one patients were enrolled and 68 completed the full 14 days of therapy (mean age 46 years; 28 men). Thirty‐three patients had failed prior treatment twice, 19 had failed three times, and 16 had failed four or more times. The cure rates were: intention to treat = 93% (66/71); (95% CI = 84% to 98%), per protocol = 97% (66/68); (95% CI = 89%– 100%). Success was excellent irrespective of diagnosis, age, prior treatment protocols, or smoking status. Moderate side‐effects were experienced by only two patients. Conclusion. Midday bismuth subcitrate based twice a day quadruple therapy was an excellent salvage therapy. BID midday quadruple regimen should be considered as the therapy of choice.